Churg-Strauss syndrome: Retrospective study in Burgundian population in France in past 10 years

Rheumatology International

Volumn 31, Issue 5, 2011, Pages 587-593

  Vinit, Julien ^a   Muller, Géraldine ^a   Bielefeld, Philip ^a   Pfitzenmeyer, Pierre ^a   Bonniaud, Philippe ^b   Lorcerie, Bernard ^b   Besancenot, Jean François ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b HÔPITAL DU BOCAGE   (France)

Author keywords

Churg Strauss syndrome; Epidemiology; Incidence; Prevalence; Vasculitis

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; MYELOPEROXIDASE;

ADULT; ARTICLE; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CORRELATION ANALYSIS; ENZYME SPECIFICITY; FEMALE; FOLLOW UP; FRANCE; HOSPITALIZATION; HUMAN; INCIDENCE; INFORMATION PROCESSING; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; REMISSION; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY; CHURG-STRAUSS SYNDROME; FEMALE; FRANCE; GUIDELINE ADHERENCE; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RESIDENCE CHARACTERISTICS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79955739492     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-009-1275-y     Document Type: Article

References (24)

1. J Churg L Strauss 1951 Allergic granulomatosis, allergic angiitis, and periarteritis nodosa Am J Pathol 27 277 301 14819261 1:STN:280: DyaG3M%2FkvVyisw%3D%3D
2. L Guillevin P Cohen M Gayraud F Lhote B Jarrousse P Casassus 1999 Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients Medicine (Baltimore) 78 26 37 10.1097/00005792-199901000-00003 1:STN:280:DyaK1M7ksVWlsQ%3D%3D (Pubitemid 29065978)
3. L Guillevin F Lhote M Gayraud P Cohen B Jarrousse O Lortholary, et al. 1996 Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients Medicine (Baltimore) 75 17 28 10.1097/00005792-199601000-00003 1:STN:280:DyaK287mtVentw%3D%3D (Pubitemid 26041085)
4. R Solans JA Bosch C Perez-Bocanegra A Selva P Huguet J Alijotas, et al. 2001 Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients Rheumatology (Oxford) 40 763 771 10.1093/rheumatology/40.7.763 1:STN:280:DC%2BD3MvivF2rsg%3D%3D
5. P Seo JH Stone 2004 The antineutrophil cytoplasmic antibody-associated vasculitides Am J Med 117 39 50 15210387 10.1016/j.amjmed.2004.02.030 1:CAS:528:DC%2BD2cXltVCqu7w%3D (Pubitemid 38798019)
6. C Ribi P Cohen C Pagnoux A Mahr JP Arene D Lauque, et al. 2008 Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients Arthritis Rheum 58 586 594 18240234 10.1002/art.23198 1:CAS:528:DC%2BD1cXivFahtL8%3D (Pubitemid 351294896)
7. P Cohen C Pagnoux A Mahr JP Arene L Mouthon V Le Guern, et al. 2007 Churg-Strauss syndrome with poor-prognosis factors: a prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients Arthritis Rheum 57 686 693 17471546 10.1002/art.22679 1:CAS:528:DC%2BD2sXmtFKhs7w%3D (Pubitemid 46764061)
8. A Mahr L Guillevin M Poissonnet S Ayme 2004 Prevalences of polyarteritis nodosa, microscopic polyangiitis, Wegener's granulomatosis, and Churg-Strauss syndrome in a French urban multiethnic population in 2000: a capture-recapture estimate Arthritis Rheum 51 92 99 14872461 10.1002/art.20077 (Pubitemid 38222288)
9. RA Watts DM Carruthers DG Scott 1995 Epidemiology of systemic vasculitis: changing incidence or definition? Semin Arthritis Rheum 25 28 34 8525388 10.1016/S0049-0172(95)80015-8 1:STN:280:DyaK28%2FisFGnuw%3D%3D
10. RA Watts MA Gonzalez-Gay SE Lane C Garcia-Porrua G Bentham DG Scott 2001 Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe Ann Rheum Dis 60 170 172 11156552 10.1136/ard.60.2.170 1:STN:280:DC%2BD3M7is1Wjsw%3D%3D (Pubitemid 32102210)
11. E Reinhold-Keller K Herlyn R Wagner-Bastmeyer WL Gross 2005 Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register Arthritis Rheum 53 93 99 15696553 10.1002/art.20928 (Pubitemid 40216357)
12. G Haugeberg R Bie A Bendvold AS Larsen V Johnsen 1998 Primary vasculitis in a Norwegian community hospital: a retrospective study Clin Rheumatol 17 364 368 9805179 10.1007/BF01450893 1:STN:280:DyaK1M%2FitF2qtw%3D%3D (Pubitemid 28483133)
13. E Reinhold-Keller K Herlyn R Wagner-Bastmeyer J Gutfleisch HH Peter HH Raspe, et al. 2002 No difference in the incidences of vasculitides between north and south Germany: first results of the German vasculitis register Rheumatology (Oxf) 41 540 549 10.1093/rheumatology/41.5.540 1:STN:280:DC%2BD38zjtVGguw%3D%3D (Pubitemid 34575305)
14. RM Martin LV Wilton RD Mann 1999 Prevalence of Churg-Strauss syndrome, vasculitis, eosinophilia and associated conditions: retrospective analysis of 58 prescription-event monitoring cohort studies Pharmacoepidemiol Drug Saf 8 179 189 15073927 10.1002/(SICI)1099-1557(199905/06)8:3<179::AID-PDS414>3.0. CO;2-K 1:STN:280:DC%2BD2c7nvFSktQ%3D%3D (Pubitemid 29286530)
15. AD Mahr T Neogi PA Merkel 2006 Epidemiology of Wegener's granulomatosis: lessons from descriptive studies and analyses of genetic and environmental risk determinants Clin Exp Rheumatol 24 S82 S91 16859601 1:STN:280: DC%2BD28vks1SisA%3D%3D
16. AJ Reid BD Harrison RA Watts SW Watkin BG McCann DG Scott 1998 Churg-Strauss syndrome in a district hospital QJM 91 219 229 9604074 10.1093/qjmed/91.3.219 1:STN:280:DyaK1c3mslCgsQ%3D%3D (Pubitemid 28115855)
17. A Della Rossa C Baldini A Tavoni A Tognetti D Neglia G Sambuceti, et al. 2002 Churg-Strauss syndrome: clinical and serological features of 19 patients from a single Italian centre Rheumatology (Oxf) 41 1286 1294 10.1093/rheumatology/41.11.1286 1:CAS:528:DC%2BD38XosFOgsr4%3D (Pubitemid 35363804)
18. KA Keogh U Specks 2003 Churg-Strauss syndrome: clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists Am J Med 115 284 290 12967693 10.1016/S0002-9343(03)00359-0 1:CAS:528: DC%2BD3sXntVChtb4%3D (Pubitemid 37088190)
19. RA Sinico L Di Toma U Maggiore P Bottero A Radice C Tosoni, et al. 2005 Prevalence and clinical significance of antineutrophil cytoplasmic antibodies in Churg-Strauss syndrome Arthritis Rheum 52 2926 2935 16142760 10.1002/art.21250 1:CAS:528:DC%2BD2MXhtFeltrbO (Pubitemid 41369124)
20. R Sable-Fourtassou P Cohen A Mahr C Pagnoux L Mouthon D Jayne, et al. 2005 Antineutrophil cytoplasmic antibodies and the Churg-Strauss syndrome Ann Intern Med 143 632 638 16263885 (Pubitemid 41552527)
21. F Lhote 2007 Churg-Strauss syndrome Presse Med 36 875 889 17408916 10.1016/j.lpm.2007.02.018 (Pubitemid 46628743)
22. T Neumann B Manger M Schmid C Kroegel A Hansch WA Kaiser, et al. 2009 Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis Medicine (Baltimore) 88 236 243 10.1097/MD.0b013e3181af35a5
23. R Phillip R Luqmani 2008 Mortality in systemic vasculitis: a systematic review Clin Exp Rheumatol 26 S94 S104 19026150 1:STN:280:DC%2BD1cfgtVyjsQ%3D%3D
24. A Bourgarit P Le Toumelin C Pagnoux P Cohen A Mahr V Le Guern, et al. 2005 Deaths occurring during the first year after treatment onset for polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: a retrospective analysis of causes and factors predictive of mortality based on 595 patients Medicine (Baltimore) 84 323 330 10.1097/01.md.0000180793.80212.17 (Pubitemid 41368485)